Biotechnology, Pharmaceuticals

French marine skincare brand « Algotherm » launched in India

Brinder Rault - 18-févr.-2019 07:46:05

  The beautiful range of skincare products from the esteemed French brand Algotherm, formulated by Laboratoires Gilbert were launched on 10 December 2018 in collaboration with Gilbert Jain Laboratory Pvt. Ltd at the Honorary French Ambassador’s residence in New Delhi.       The company has also inaugurated their new training centre in Old Rajender Nagar, New Delhi. They plan to train people through beauty salons, which will be a part of various training centres and also their principal clients. Further, they will also adopt the omni-channel strategy and target to sell online via Amazon, Flipkart and Nykaa.       A wide variety of products ranging from creams, serums, masks to correctors and gels, ’Algotherm’ products are all natural and are made from Algohydra which hydrates and nourishes the skin along with moisturizing. Borrowing from the goodness of the sea and adding the richness of 29 unique, marine ingredients, ’Algotherm’ is best known for its algae-infused personal care range.       Algotherm is committed to sustainability in its practices of collecting and processing the natural ingredients used.  


TAMI Industries’ ceramic membranes are renowned in the field of membrane separation processes for their durability and extreme efficiency

Purva Marwaha - 03-juil.-2017 08:07:47

      TAMI Industries’ ceramic membranes are renowned in the field of membrane separation processes for their durability and extreme efficiency   Specially adapted for the food processing, pharmaceutical and biotechnological industries.       The use of ceramic membranes has increased in popularity over recent years in the various industrial separation processes currently available on the market. Their characteristics of high mechanical resistance, durability and ease of use have contributed significantly to this increased popularity.       Although representing only 10% of the global market, in very many applications ceramic membranes are challenging organic membranes. The main advantages they offer being greater durability, significant chemical stability, complete temperature independence and improved mechanical resistance to pressure. Thus, corrosive products, steam sterilization, high-temperature separations or hydraulic accidents in circulation pumps are easy to control using ceramic membranes.       TAMI Industries’ R&D department has gone to considerable lengths to develop new inorganic membranes. This hard work has resulted in the creation of high-tech ceramic membranes with the exclusive characteristics of non-circular petal-shaped channels. Compared to circular channels, non-circular channels provide a larger filtration surface for the same external volume of the membrane thus ensuring improved filtration performance as well as increased turbulence and reduced fouling.       The original shapes of the ceramic membranes designed by TAMI Industries means they are more compact (patents on non-circular channels), which increases permeability and offers a wide choice of cut-off thresholds - Microfiltration, Ultrafiltration and Fine Ultrafiltration (patents on the layers), high mechanical resistance (patent on the base materials), significant chemical stability (pH range from 0 to 14), high heat resistance (up to 300 °C ), low risk of fouling, reliability and durability (an average useful life 3 to 4 times longer than their organic competitors).       The external dimensions of TAMI Industries’ ceramic membranes are compatible with all existing equipment and facilities on the market that use ceramic membranes. This functionality means that renovating industrial infrastructures is simple, only the ceramic membranes need to be replaced (process known as RETROFIT).       As a result of this R&D investment it is now possible to offer membranes with the best filtration surface /external volume ratio of the membrane associated with control over the shaping of the membrane’s materials, thus allowing very narrow distributions of the pore diameters and a more uniform performance. In addition, investments in external growth have guaranteed the manufacture of the supports, which means that TAMI Industries has complete control of the ceramic membrane production process from start to finish.       This investment has led to a significant improvement in performance and, therefore, increased energy savings, along with lower operating and infrastructure maintenance costs.       There are two separate ranges of ceramic membranes available:-   - A range of tubular shaped products for industry (Inside CéRAM)   - A range of flat products for frontal and cross-flow filtration for laboratory tests (Inside KéRAM).       Currently, TAMI Industries is the only company in the world capable of producing and offering such high-performance tubular ceramic membranes on an industrial scale.       Main fields of application:-   - pharmaceutical and biotechnological sectors - culture media clarification (production of amino acids, antibiotics, enzymes, vitamins, etc.)                   - food-processing sector – debacterization of milk, fractionation, standardization and concentration of milk and lactoserum (WPI/WPC), clarification of wines, fruit juices, cider and sweetened juices …                   - environmental sector – treatment of metallurgy effluents, oil/water separation (degreasing baths), laundry water, paper industries and textile industries effluent treatment…       This list is far from exhaustive, ceramic membranes can fulfill the requirements of numerous other applications.       The Indian Market has great potential for these ceramic membranes since all the sectors of application are recording double digit growth. Tami Industries has been present in India since the past 10 years and is supplying these membranes via partners. The French company is now looking to expand its operations in the Western & Southern regions of India and is therefore looking for partners who can import & distribute their products in India.       TAMI Industries, your ideal partner for all your filtration processes, is looking for partners to help with the commercial development of its products.       About TAMI Industries:   TAMI Industries, designs and manufactures industrial filters (ceramic membranes) for the separation of molecules or particles contained in liquids. It operates in the fields of Fine Ultrafiltration, Ultrafiltration and Microfiltration. TAMI offers a wide range of cut-off thresholds – microfiltration, ultrafiltration and fine ultrafiltration.   TAMI Industries , head office in Nyons (South-East France), is a global player in the ceramic membranes sector, 85% of its revenue being achieved internationally. Currently, TAMI Industries has four subsidiaries abroad, in Germany, Canada, Mexico and China.       For further information, please contact us or visit our website: www.tami-industries.com   About Business France:   Business France is the national agency supporting the international development of the French economy, responsible for fostering export growth by French businesses, as well as promoting and facilitating international investment in France. It promotes France’s companies, business image and nationwide attractiveness as an investment location, and runs the V.I.E international internship program. Business France has 1,500 personnel, both in France and in 70 countries throughout the world, who work with a network of public- and private-sector partners. For further information, please visit: www.businessfrance.fr and youbuyfrance.com.in .         Press contact:   Ms. Purva Marwaha   Business France, French Trade & Investment Commission in India   Trade Officer. Tel: 011 4319 6306 / @: purva.marwaha@businessfrance.fr       Company Contact:   Vincent GELEZEAU,   TAMI Industries, Area Manager   Tel.: + 33 (0)4 75 26 47 69   E-mail: vgelezeau@tami-industries.com  


High level discussion on "Next Generation of Infection Prevention"

Julian HOARAU - 06-oct.-2016 06:59:43

  High level discussion on “ Next Generation of Infection Prevention” within the framework of the “Make in India” program   Business France has successfully organized two interactive sessions for the French company Schülke, 100% subsidiary of Air Liquide Group on “ Next Generation of Infection Prevention”. The seminar was held in the presence of H.E Mr Alexander ZIEGLER, Ambassador of France in India at the Residence of France in New Delhi on Tuesday, on 27 th September and the second one was held at the hotel Taj Coromandel, Chennai on 29th September with the participation of the Consul General of France in Pondicherry.   This event shaped an Indo-French discussion & created awareness on important topics; nosocomial infections, health care guidelines, desired standards of hospital hygiene & infection control and efficiency & application of next generation products.   The discussion also highlighted french creativity via the launch of innovative products in the area of healthcare by Schülke and celebrated the success of their flagship brand Microshield, a product which is well known among healthcare professionals in India and has been in existence for 25 years. The interactive sessions gathered together more than a 100 participants; senior Indian government officials, medical directors & CEO’s from public and private hospitals, senior healthcare professionals and the Indian & French business communities respectively.     The dual seminars concretely demonstrated the initiatives taken by French companies to bring the most recent technologies available in Europe to India, to adapt them to the Indian context and manufacture them in India to benefit the larger interests of the healthcare sector in India.  


Schülke celebrates 25 years of Microshield® success in India

Julian HOARAU - 28-sept.-2016 12:07:10

    Schülke celebrates 25 years of Microshield® success in India   Schülke India Pvt Ltd, 100% subsidiary of the French groupe Air Liquide celebrated today, in the presence of the Ambassador of France in India, H.E. Alexander Ziegler, 25 successful years of Microshield. The company specializes in hygiene and preservation and their mission is to fight disease and contamination before they emerge.   Schulke welcomed Microshield® into its family of infection prevention products in February this year. For more than a century Schülke has been working towards fighting disease and contamination. This association promises to further bring innovation and new products to market and reduce the risk of infection.   “India is a strategic market for Schülke. We will continue to further develop the strong Microshield brand in India and we are committed to add value to our customers, whether it is through products or through services.   We have an excellent team in place. Customers can expect from Schülke innovative Hygiene Solutions from Experts – for Experts!” says Alexander Mueller, General Manager,Asia Pacific   Since India is such an important market for the company, Schulke has also launched a state of the art molecule called Octenidine which is a result of the company’sinvestment & commitment to R&D. Due to its excellent antimicrobial efficacy and tissue compatibility, Octenidine may be used for different topical applications applicationsin the field of infection prevention /product contamination in the form of Drugs, Medical devices & Cosmetic products, where fast action and a long lasting effect are required. Examples for such applications are the decontamination of skin of patients colonised with MRSA, the treatment of acute and chronic wounds heavily colonised or locally infected by pathogenic bacteria and the care of central venous catheter insertion sites. With octenidine a highly effective and compatible innovative antimicrobial compound for topical use is available.   Schulke currently has some products based on Octenidine available in India like Octenisan Wash Lotion, Octenisan Wash Mitts and Octenidol Mouthwash. The company plans to launch more products in the near future reaching out to more patients.   According to the World Health Organisation, hands are a major source that lead to the spreading of hospital acquired infections and in 2009 the WHO published guidelines on hand hygiene in Health Care. Therefore, a lot of emphasis and awareness has been placed on the importance of proper hand hygiene.   About Schülke India:   Schülke and Mayr GmbH wasfounded in 1889 by Rudolf Schülke and Julius Mayr. Since 1996, we have been a 100 % subsidiary of the *Air Liquide Group, world leader in gases, technologies and services for industry and health. Our headquarters in Norderstedt near Hamburg are the focal point of all our activities. Here, all of our central divisions work hand in hand: from Research and Development, Management, Production and Marketing, to Sales and Logistics. As one of the market leaders in infection control, we provide major impetus from here: for our continuous global growth – and for successful hygiene solutions for our customers. The quality of a whole hygiene chain is equal only to that of each link within that chain. That is why we are uncompromising in our holistic approach. In this way, we create more than economic success: sustained value for the environment and society.   Schülke has been driving its transformation from a tradition-steeped chemical enterprise to a modern partner for the pharmaceutical and chemical industries. With 15 international subsidiaries and a presence in more than 80 countries, the company generates an annual turnover of more than 250 million Euro. Disinfectants, antiseptics, preservatives, biocides, medical skin care products, active ingredients for deodorants and system cleaners form the main focus of the range of products that the company develops and produce.   They have a national presence in all the major cities in India to support Healthcare Professionals in Hospitals and Nursing Homes and offices in Delhi, Mumbai and Chennai”   For more about the history and heritage of the company, you can visit our website: http://www.schuelke.co.in/in-en/   *Air Liquide Healthcare Supplies medical gases, home healthcare services, hygiene products, medical equipment and specialty ingredients . In 2015, it served over 7,500 hospitals and more than 1.3 million patients at home throughout the world. The Group’s Healthcare business reached € 2,799 million in revenues in 2015 , with the support of its 13,500 employees . *These data do not include Airgas, whose acquisition was completed on May 23, 2016.       About Business France:   Business France is the national agency supporting the international development of the French economy, responsible for fostering export growth by French businesses, as well as promoting and facilitating international investment in France.It promotes France’s companies, business image and nationwide attractiveness as an investment location, and also runs the V.I.E international internship program. Business France has 1,500 personnel, both in France and in 70 countries throughout the world, who work with a network of public- and private-sector partners.For further information, please visit: www.businessfrance.fr and youbuyfrance.com.in .   Company contacts:   Mr Deep Sharma   Managing Director   Schulke IndiaPvt Ltd   @: Deep.Sharma@schuelke.com       Press contact:   Ms. PurvaMarwaha   Business France, French Trade Commission in India   Trade Officer. Tel: 011 4319 6306   @: purva.marwaha @businessfrance.fr  


Urgo takes a minority stake in a company in India

Purva Marwaha - 19-avr.-2016 09:01:23

Aiming to flourish its wings in Indian market, France-based life sciences group URGO today said it has taken equity share in Eucare, a pharmaceuticals firm, for forging an alliance in area of burns, advanced wound care, surgical hemostasis and dental regeneration concepts. Former French President Nicolas Sarkozy signed a strategic partnership deal on behalf of URGO and S Sridharan from Eucare Pharmaceuticals. "We are excited to set foot in India with the support and experience of our new partner. Eucare is a partner with strong market presence, manufacturing, regulatory and R&D capabilities. URGO will now be able to provide its internationally recognised and scientifically proven TLC based wound dressing concepts to all Indian patients," Pierre Moustial, General Director, URGO Group told UNI on the sidelines of a FICCI event. URGO will start its operation from Chennai and in future it will take to other parts of the country. ’’We will now benefit from URGO’s global network in serving newer international markets. The partnership will enable us to access URGO Group’s global expertise in the areas of clinical research, manufacturing, regulatory and marketing,’’ Mr Sridharan said. He also said cost effective products will be provided to diabetic wounded patients. Mr Sridharan further added both the companies will dedicate their efforts to work hand in hand with public and private hospitals to set higher standards for wound care treatments. He also said URGO and Eucare would aim to become the caring partner of all major hospitals across the country. However, Mr Moustial refuses to reveal the amount of investment in India. 


Gattefossé opens new premises in Mumbai, India

Thomas ILHE - 14-sept.-2015 08:21:53

Subsequently growth in its business activity in India initiated Gattefossé group to expand its presence in the  country through the  establishment of a technical centre of excellence. This new facility reinforces the activity of its affiliate, Gattefossé India, run by Mr Sunil Bambarkar. This new  office   and  technical centre is officially  inaugurated  on  11th  September,  2015 with the distinguished presence of Mr. Jacques Moyrand, Gattefossé group Chairman, Mr Agit Singh, Chairman, AGC  Worldwide Associated Capsule Pvt Ltd. and Mr Yves Perrin, The Consul  General of France. The centre brings together a FDA* certified laboratory for pharmaceutical applications to facilitate the use of API’s** in formulations as well as a state-of-the-art personal care laboratory on surface area of 325 m² (3500 sqft). The staff specialists provide an essential technical interface for customers throughout India and beyond using these tools and apparatus. These new premises aim  at facilitating the  research and formulation work and consolidating the  local assistance to customers. Olivier Midler, CEO of Gattefossé group describes its vision for the  future: “ Our growth  strategy for the company is based on  two  main pillars; innovation, by pursuing  our  significant investments  in R&D and  product  applications, and geographical  expansion by developing  our  business and expertise in new territories. All these efforts to ensure our customers a responsive and adapted service specific to their markets .” About Gattefossé India: Gattefossé India is a decade run  strategic supplier for cosmetics and pharmaceuticals companies in India. This Gattefossé affiliate is responsible for sales, marketing and technical service support throughout the Indian subcontinent. It sustains a profitable operation, supported by a professional team of business development, technical and customer service as well as administration managers. Gattefossé India extends extensive regulatory, toxicological support, technical and application guidance to the  pharmaceutical and personal care customers. Various workshops, texture showcase and seminars are organised by experts for detailing benefits of Gattefossé products. About Gattefossé Group: Gattefossé develops, manufactures and sells specialty ingredients for the personal care and pharmaceutical industries and offers a strong expertise in formulation for both of these activities. Gattefossé markets its products in more than 60 countries through 13 affiliated companies and a network of agents and distributors which operate technical and marketing support: 75% of the sales are achieved on the export markets. Innovation, ethics, quality and stability are the company key-drivers since the beginning. Gattefossé was founded in Lyon, France in 1880 by Mr Louis Gattefossé to whom building strong relationship with customers was a priority. The company still is a family-run  and independent business, and now  employs 280 people worldwide.  


Shantha Bio receives WHO nod for Pentavalent Vaccine

Anindita BANERJEE - 14-mai-2014 13:46:31

Shantha Biotechnics, a Sanofi group company, today said its paediatric pentavalent vaccine Shan5, developed and manufactured indigenously, has received prequalification status from the World Health Organisation (WHO). The status qualifies Shan5 vaccine for purchase by United Nations agencies, mainly UNICEF, said Harish Iyer, Shantha CEO in a media briefing here. "Shan5 prequalification will give more children around the world access to the latest high-quality, fully-liquid, 5-in-1 vaccine and help secure the supply of pentavalent combination vaccines in over 50 emerging and low-income countries," Iyer said. Pentavalent vaccine provides effective protection for children from 6 weeks of age against five diseases: diphtheria, tetanus, pertussis, Hib and hepatitis B. Replying to query, he said Sanofi has invested over Rs 1,000 crore in Shantha since its acquisition in 2009. He said the demand for the vaccine is around 200 million vials and the company is expecting to garner good chunk of market share in future. An earlier version developed by the vaccine maker was recognised by WHO and the company sold 18 million doses between 2008 and 2010. However, it was later withdrawn due to some issues in the sedimentation of the vaccine. Varaprasad Reddy, founder of Shantha Biotechnics and Non-Executive Chairman of the board said they are committed and focused to the priority and passion which is to serve people through high quality, affordable vaccines. Source : PTI


About
  Lifestyle, Consumer Goods and Healthcare The Consumer Goods and Healthcare Department assistsFrench companies in their international development strategy and promotes trade between France and India. In order to maximize commercial opportunities between French and Indian companies, the Department organises French Pavilions at a number of key exhibitions in India, as well as offering other B2B networking events and individual partnering services. The Department provides expertise in : • Fashion and Accessories • Home Furnishing and Interior Design • Cosmetics, OTC and Natural products • Healthcare Equipment and Biotechnology Head of Department  : Ms. Brinder RAULT brinder.rault@businessfrance.fr

READ MORE

Facebook
Press area & Media Gallery
List of last comments

Bluestorage is a subsidiary of the Bollo...

Malcolm MESSIER | février 22, 2019

AdBGQi Thank you for this impressive rep...

best pron | janvier 29, 2018

pYktcT Well I definitely liked studying ...

just another | novembre 08, 2017

dv1KAR Say, you got a nice post.Thanks A...

best pron | septembre 20, 2017